BioWorld Science

RSS

Addex and Indivior sign licensing and collaboration agreement for ADX-71441 to treat addiction

Jan. 3, 2018

New anti-BCMA-CAR therapy for MM shows promise in preclinical phase

Jan. 3, 2018

FDA accepts Olinvo NDA

Jan. 3, 2018

Tetraphase submits NDA for intravenous eravacycline to treat cIAI

Jan. 3, 2018

Achaogen reports topline results from first clinical trial of C-Scape

Jan. 3, 2018

FDA grants breakthrough therapy designation to Kisqali for premenopausal breast cancer

Jan. 3, 2018

Five Prime initiates phase I portion of FIGHT trial of FPA-144 in advanced gastric cancer

Jan. 3, 2018

Centrexion Therapeutic raises funds for phase III development of CNTX-4975

Jan. 3, 2018

FDA grants priority review to Achaogen's plazomicin NDA

Jan. 3, 2018

IQGAP1 identified as a potential therapeutic target for AML treatment

Jan. 3, 2018